ArticleScientific reports2026
Gasless endoscopic thyroidectomy via the trans-subclavian approach versus conventional open thyroid surgery for unilateral thyroid cancer.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The incidence of papillary thyroid carcinoma (PTC) is increasing worldwide. With advancements in society and technology, the variety of thyroid endoscopic surgeries is expanding. Gasless endoscopic thyroidectomy via the trans-subclavian approach (GETTSA) has been used for many years; yet, relevant research data are limited. This study aimed to assess the reliability of GETTSA by comparing it with conventional open thyroid surgery (COT). Clinical data were collected from 488 patients who underwent unilateral PTC surgery at Yantai Yuhuangding Hospital. Based on propensity score matching, relevant data were compared between the two procedures using the chi-square test, independent-sample t-test, and Mann-Whitney U test. COT and GETTSA significantly differed with respect to Thyroid Cancer-Specific Quality of Life (P < 0.001), scar appearance (P = 0.031), swallowing function (P = 0.001), operative time (P < 0.001), hospital fees (P < 0.001), number of central lymph node dissections (P < 0.001), drainage volume on the first postoperative day (P = 0.017), and parathyroid autotransplantation(P = 0.019). However, no notable differences in the number of lymph node metastases (P = 0.155), length of postoperative hospital stay (P = 0.181), or transient vocal cord paralysis (P = 0.478) were observed between COT and GETTSA. Additionally, no complications (secondary surgery, tracheal fistula, poor healing, or postoperative bleeding) occurred in either group. In conclusion, GETTSA is a reliable surgical procedure with the help of carbon nanoparticles; however, attention should be paid to protecting the parathyroid glands.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.